Muscular Dystrophy
What's New
Last Posted: Sep 13, 2023
- Lessons learned from the first national population-based genetic carrier-screening program for Duchenne Muscular Dystrophy.
A Singer et al, Genetics in Medicine, September 12, 2023 - Neuromuscular disease genetics in underrepresented populations: increasing data diversity.
Lindsay A Wilson et al. Brain 2023 - For Duchenne moms who pushed for cures, new breakthrough therapy can’t rebuild what’s lost
J Mast, Stat News, June 30, 2023 - Newborn screening for Duchenne muscular dystrophy: A two-year pilot study.
Norma P Tavakoli et al. Ann Clin Transl Neurol 2023 - Duchenne Muscular Dystrophy Gene Therapy in 2023: Status, Perspective, and Beyond.
Dongsheng Duan et al. Hum Gene Ther 2023 34(9-10) 345-349 - Racial and ethnic differences in timing of diagnosis and clinical services received in Duchenne Muscular Dystrophy.
Joshua R Mann et al. Neuroepidemiology 2023 - Muscular dystrophy gene therapy nears approval, but safety concerns linger Use of viruses poses significant risks and, for now, prevents retreatment if benefits fade
J Kaiser, Science, May 23, 2023 - Multi-Laboratory Evaluation of Prototype Dried Blood Spot Quality Control Materials for Creatine Kinase-MM Newborn Screening Assays.
Paul Dantonio et al. International journal of neonatal screening 2023 9(1) - The Dilemma of Choice for Duchenne Patients Eligible for Exon 51 Skipping The European Experience.
Annemieke Aartsma-Rus et al. Journal of neuromuscular diseases 2023 - Smartphone and Wearable Sensors for the Estimation of Facioscapulohumeral Muscular Dystrophy Disease Severity: Cross-sectional Study.
Ahnjili Zhuparris et al. JMIR formative research 2023 7e41178
More
About ND PHGKB
Neurological Disorders (ND) PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to neurological disorders....more
Content Summary
Common ND Related Topics
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2023
- Page last updated:Oct 03, 2023
- Content source: